Atul D. Bali, MD

1.9K posts

Atul D. Bali, MD banner
Atul D. Bali, MD

Atul D. Bali, MD

@ABaliMD

Interventional Cardiologist @lenoxhill / @ZuckerSoM🫀| Interests #CHIP #PERT #CardiacCriticalCare | Previously @nymedcollege @PennMedicine | tweets are my own |

New York, NY Katılım Mart 2017
599 Takip Edilen1.4K Takipçiler
Atul D. Bali, MD retweetledi
AHA Science
AHA Science@AHAScience·
Key updates to this guideline include: ➡️ The use of the American Heart Association PREVENT-ASCVD equations to guide primary-prevention and lipid-lowering therapy decisions. ➡️ Testing Lp(a) at least once in a lifetime and selective apolipoprotein B measurement to improve risk assessment and guide treatment ➡️ The return of LDL-C and non-high-density lipoprotein cholesterol treatment goals (with lower targets for higher-risk groups) ➡️ Expanded use of coronary artery calcium scoring to reclassify risk[ME1.1] ✍🏼 @rblument1 @tygluckman @RonBlankstein @PamelaBMorris @pnatarajanmd @AnnMarieNavar @SethShayMartin @APRN_CNS @nyulangone @DrMichaelShapir @kgradneyrd @eugeniagianos @virani_md @KellieMcLain1 @ijeomaheartdoc @SamiaMoraMD @DrHeatherJohn @dmljmd
AHA Science tweet media
English
7
143
313
102.6K
Atul D. Bali, MD
Atul D. Bali, MD@ABaliMD·
@AdityaMandawat DES for sure. Long term outcome with covered stent will be poor. DAPT - standard duration should be fine, after which I’ve done P2Y12 monotherapy over aspirin (which is becoming my standard as of late) Had a similar case a few months back:
Atul D. Bali, MD tweet media
English
1
0
3
303
Aditya Mandawat, MD
Aditya Mandawat, MD@AdityaMandawat·
How are folks dealing with lesions that involve an aneurysmal segment? DES or covered stent? Any changes to antiplatelet strategy? Anticoagulation?
Aditya Mandawat, MD tweet mediaAditya Mandawat, MD tweet media
English
15
4
36
5.5K
Atul D. Bali, MD
Atul D. Bali, MD@ABaliMD·
2/ Piling on to finish the call weekend: Acute stent thrombosis of metal jacket LAD done a few days prior. With double layer in the prox SCAI D AMI cardiometabolic shock Multiple aspiration, repeated PTCA, distal vasodilators, MCS, lots of drugs Very tough thrombus burden
English
0
0
1
310
Atul D. Bali, MD
Atul D. Bali, MD@ABaliMD·
What a Christmas 🎄 call VT/electrical storm needing #ECMO Valvular #cardiogenicshock needing salvage BAV Mid LAD #STEMI w/ critical LM bifurcation disease Tamponade w/ hemorrhagic effusion & a CCU that has not let up, all during a snowstorm! Wouldn’t have it any other way 🙏🏽
Atul D. Bali, MD tweet mediaAtul D. Bali, MD tweet mediaAtul D. Bali, MD tweet mediaAtul D. Bali, MD tweet media
English
7
8
100
14.4K
Atul D. Bali, MD
Atul D. Bali, MD@ABaliMD·
@ISeropianMD @imedCV Apologies - I meant PCI prox-mid LAD, provisional across the diagonal, after focal stent in the mid diagonal
English
0
0
1
69
Ignacio Seropian MD
Ignacio Seropian MD@ISeropianMD·
How would you great this 79 yo 👵🏻 su total LAD + Diag (huge) … it’s a pre #TAVI case from @imedCV ➡️ 2 stents upfront (DKC)? ➡️. Provisional witj bailoit TAP? ➡️. LAD distal to diag + diag ‘mail the ostium’ ?
English
2
4
14
2.5K
Atul D. Bali, MD
Atul D. Bali, MD@ABaliMD·
4/ Procedural clips and IVUS post stenting (post dilation performed after) Will decide on RCA based on symptoms given cardiomyopathy.
English
0
0
1
225
Atul D. Bali, MD
Atul D. Bali, MD@ABaliMD·
3/ Ostial LM CSA - 3.2, severe dampening. 7Fr w/ SH, single access w/ tMCS Wiring was tricky! Took an XTA & was able to wire into a septal off the aneurysm, then direct down to LAD Up-front Rota 1.5 through LM -> mid LAD, IVUS sized DESx2 mid LAD to Ostial LM. (Bumper wire)
English
1
0
0
302
Atul D. Bali, MD
Atul D. Bali, MD@ABaliMD·
Last weeks complex case: 60s, dilated CDM (LV 6.8cm, EF 20%). P/w refractory angina, limited meds due to low BP on GDMT Not sick enough for transplant yet (ambulatory, CI 2.5, on oral 💊). Surgical turndown due to risk 🫀team➡️ PCI for QOL/angina How would you approach? #CHIP
Atul D. Bali, MD tweet mediaAtul D. Bali, MD tweet media
English
4
2
7
983
Said Ashraf MD, FACC, FSCAI
Said Ashraf MD, FACC, FSCAI@SaidAshrafMD·
Halloween Haunt: Male 60s with chest pain for 1 hour, EKG with STE in AVR & wide spread depressions. Hemodynamically stable ➡️ CCL ➡️ here’s what angio showed. After the second Left cors shot became acutely 🤢, hemodynamics collapsed hypotension + respiratory failure. What would you do next?
English
8
9
60
15.4K
Atul D. Bali, MD
Atul D. Bali, MD@ABaliMD·
High risk PE on call last night🫀p/w syncope & ⬇️ BP Heavily impacted bilateral PE w/ saddle, RV/LV 1.6. Opening hemos c/w normotensive shock (on inotropes CI 1.4). MCS on standby. Immediate response to thrombectomy. POD1 - walking, normal RV fxn on TTE. #PERT @PERTConsortium
Atul D. Bali, MD tweet media
English
29
55
530
46.9K
Atul D. Bali, MD
Atul D. Bali, MD@ABaliMD·
@Miazolam @Jonathan_PaulMD @PERTConsortium @InariMedical Unless its a true salvage situation, if there is a PE operator/cath lab available high-risk PE should be treated w/ intervention. Original data for lytics is shaky at best, w/⬆️ adverse events. Modern data for thrombectomy in HRPE is excellent both for mortality benefit & safety
English
0
0
1
32
Ignacio Seropian MD
Ignacio Seropian MD@ISeropianMD·
@AntoniousAttall Does anybody now when results are going to be presented? I’m really looking forward for this trial, PEERLES II & PE-TRACT!!!! 🙏 Unfortunately STORM-PE doesn’t look as good (only 100 pt and RV/LV as EP)
English
2
0
3
293
Antonious Attallah, MD, FACC, FSCAI
Antonious Attallah, MD, FACC, FSCAI@AntoniousAttall·
congrats to all...along with #stormPE, this will be field defining. Hopefully an indication that we have been walking the right direction for the last decade...
Cat Jennings@bsc_vascular

Big News! The 544th—and final—patient has been enrolled in #HIPEITHO, a landmark RCT comparing EKOS + anticoagulation vs. anticoagulation alone in intermediate-high risk #PE. Thank you to our investigators, @PERTConsortium & @UnimedizinMainz. Learn more: bit.ly/44VQapx

English
1
1
13
2.1K
Jay Giri
Jay Giri@jaygirimd·
@ABaliMD @pritish_iyer @PERTConsortium @InariMedical Similar to MI and stroke, we need randomized data in this area to justify this practice. Good news is trials enrolling (with one complete). But important that all these patients get enrolled if presenting to trial sites as true risk/benefit is unknown.
English
1
0
5
237
Atul D. Bali, MD retweetledi
Miguel Alvarez Villela
Miguel Alvarez Villela@MAlvarezVillela·
This week we hosted the first edition of the Northwell Cardiogenic Shock Skills day. Over 50 junior faculty members and fellows from cardiology, IC, CTS & CCM joined a day of hemodynamic simulations, hands-on tMCS and PAC learning and expert discussions of real-life CS cases.
Miguel Alvarez Villela tweet mediaMiguel Alvarez Villela tweet mediaMiguel Alvarez Villela tweet mediaMiguel Alvarez Villela tweet media
English
1
1
11
602
Atul D. Bali, MD
Atul D. Bali, MD@ABaliMD·
@pritish_iyer @PERTConsortium @InariMedical We base our strategy on evolving data. PE is following the same path is MI. 1st lytic era & now interventional era. Tricky part is the int-risk - innately low mortality, but rapid symptom relief is very important to pts, & long term prevention of CTED/PH? Questions remain still
English
1
0
4
237
Atul D. Bali, MD
Atul D. Bali, MD@ABaliMD·
@pritish_iyer @PERTConsortium @InariMedical Yes. If there’s evidence of RV strain on imaging, enzyme positivity, & symptoms either rest or exertional, we are intervening on intermediate risk PE routinely. Every PE is screened by our PERT pathway too and we have a rapid multidisciplinary discussion
English
1
0
7
776